sodium;(5R,6R)-3-tert-butyl-7-oxo-6-[[3-[(2-phenylacetyl)amino]propanoylamino]methyl]-4-oxa-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate

ID: ALA74235

Max Phase: Preclinical

Molecular Formula: C22H26N3NaO6

Molecular Weight: 429.47

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(C)(C)C1=C(C(=O)[O-])N2C(=O)[C@H](CNC(=O)CCNC(=O)Cc3ccccc3)[C@H]2O1.[Na+]

Standard InChI:  InChI=1S/C22H27N3O6.Na/c1-22(2,3)18-17(21(29)30)25-19(28)14(20(25)31-18)12-24-15(26)9-10-23-16(27)11-13-7-5-4-6-8-13;/h4-8,14,20H,9-12H2,1-3H3,(H,23,27)(H,24,26)(H,29,30);/q;+1/p-1/t14-,20+;/m0./s1

Standard InChI Key:  UUULFEZBHRPQFL-OWKALNPCSA-M

Associated Targets(non-human)

blaZ Beta-lactamase (285 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Beta-lactamase (42 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 429.47Molecular Weight (Monoisotopic): 429.1900AlogP: 1.01#Rotatable Bonds: 8
Polar Surface Area: 125.04Molecular Species: ACIDHBA: 5HBD: 3
#RO5 Violations: 0HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 4.01CX Basic pKa: CX LogP: 0.31CX LogD: -2.84
Aromatic Rings: 1Heavy Atoms: 31QED Weighted: 0.53Np Likeness Score: -0.25

References

1. Wild H, Metzger K.  (1993)  Substituted 6-alkyloxapenems: potent -lactamase inhibitors: synthesis and biological characterization,  (11): [10.1016/S0960-894X(01)80926-4]

Source